Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransCode Therapeutics Inc.

0.3000
+0.027510.09%
Post-market: 0.2972-0.0028-0.93%18:23 EDT
Volume:13.29M
Turnover:4.44M
Market Cap:7.00M
PE:0.00
High:0.3850
Open:0.2784
Low:0.2784
Close:0.2725
Loading ...

Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast

Benzinga
·
26 Feb

Transcode Therapeutics Inc trading resumes

TIPRANKS
·
22 Feb

Top Midday Gainers

MT Newswires Live
·
07 Feb

Transcode Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Feb

Promising Clinical Developments Drive Buy Rating for TransCode Therapeutics

TIPRANKS
·
06 Feb

Transcode Therapeutics Announces Completion of Cohort 3 Initial Dosing With Lead Candidate in Phase 1 Clinical Trial

THOMSON REUTERS
·
06 Feb

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial

PR Newswire
·
06 Feb

Transcode Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
05 Feb

TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting

PR Newswire
·
05 Feb

Transcode Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
28 Jan

Transcode Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
24 Jan

Transcode Therapeutics Announces First Patient Dosed in Third Cohort With Lead Candidate in Phase 1 Clinical Trial

THOMSON REUTERS
·
14 Jan

Transcode Therapeutics Inc - No Significant Safety or Dose Limiting Toxicities in Cohorts 1 and 2

THOMSON REUTERS
·
14 Jan

TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial

PR Newswire
·
14 Jan

BRIEF-Transcode Therapeutics Inc Nasdaq Determines Co Has Regained Compliance With Continued Listing Requirements

Reuters
·
07 Jan

Transcode Therapeutics regains Nasdaq compliance

TIPRANKS
·
07 Jan

Transcode Therapeutics Inc: Nasdaq Determines Co Has Regained Compliance With Continued Listing Requirements

THOMSON REUTERS
·
07 Jan

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

PR Newswire
·
07 Jan

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), TransCode Therapeutics (RNAZ)

TIPRANKS
·
19 Dec 2024

Transcode Therapeutics Inc : H.c. Wainwright Adjusts Target Price to $20 From $3 After Reverse Stock Split

THOMSON REUTERS
·
19 Dec 2024